These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 10333001)
1. Prevalence of antikeratin antibodies in an elderly population. Maillefert JF; Piroth C; Olsson NO; Gros F; Milas L; Wautot A; Tavernier C J Rheumatol; 1999 May; 26(5):1214-5. PubMed ID: 10333001 [No Abstract] [Full Text] [Related]
2. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection. Cojocaru M; Cojocaru IM; Iacob SA Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142 [TBL] [Abstract][Full Text] [Related]
3. [Early appearance of antikeratin antibodies]. Le Goff P; Youinou P; Jouquan J Rev Rhum Mal Osteoartic; 1986 Dec; 53(12):699-700. PubMed ID: 2434983 [No Abstract] [Full Text] [Related]
4. [Antikeratin antibodies: another specific antibodies in rheumatoid arthritis patients]. Zhou Z; Jiang M; Wang H Zhonghua Nei Ke Za Zhi; 1995 May; 34(5):330-2. PubMed ID: 8565719 [TBL] [Abstract][Full Text] [Related]
5. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis]. Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821 [TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis associated autoimmune systems. Ménard HA; El Amine M; Després N J Rheumatol; 1998 May; 25(5):835-7. PubMed ID: 9598876 [No Abstract] [Full Text] [Related]
7. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Salvador G; Gomez A; Vinas O; Ercilla G; Canete JD; Munoz-Gomez J; Sanmarti R Rheumatology (Oxford); 2003 Aug; 42(8):972-5. PubMed ID: 12730510 [TBL] [Abstract][Full Text] [Related]
8. Amtiperinuclear factor and antikeratin antibody: diagnostic use in a clinical laboratory setting. Alnigenis MN; Warikoo S; Barland P J Rheumatol; 2000 Aug; 27(8):2056-7. PubMed ID: 10955361 [No Abstract] [Full Text] [Related]
9. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797 [TBL] [Abstract][Full Text] [Related]
10. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Paimela L; Gripenberg M; Kurki P; Leirisalo-Repo M Ann Rheum Dis; 1992 Jun; 51(6):743-6. PubMed ID: 1377463 [TBL] [Abstract][Full Text] [Related]
11. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
12. New autoantibodies in rheumatoid arthritis. Le Goff P; Saraux A; Youinou P Rev Rhum Engl Ed; 1997 Nov; 64(11):638-44. PubMed ID: 9413888 [No Abstract] [Full Text] [Related]
13. Diagnostic role of antikeratin antibodies in RA. Adebajo AO; Hazleman BL; Williams DG; Maini RN Ann Rheum Dis; 1992 Nov; 51(11):1264. PubMed ID: 1281627 [No Abstract] [Full Text] [Related]
14. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Nogueira L; Sebbag M; Vincent C; Arnaud M; Fournié B; Cantagrel A; Jolivet M; Serre G Ann Rheum Dis; 2001 Sep; 60(9):882-7. PubMed ID: 11502616 [TBL] [Abstract][Full Text] [Related]
15. [Novel autoantibodies for the diagnosis of rheumatoid arthritis]. Steiner G; Smolen JS Z Rheumatol; 2002 Dec; 61(6):667-73. PubMed ID: 12491130 [TBL] [Abstract][Full Text] [Related]
16. Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Scott DL; Delamere JP; Jones LJ; Walton KW Ann Rheum Dis; 1981 Jun; 40(3):267-71. PubMed ID: 6166256 [TBL] [Abstract][Full Text] [Related]
17. [Antimitochondrial antibodies and other non-organ-specific autoantibodies in rheumatoid polyarthritis]. Meyer O; Guessous M; Ryckewaert A; Homberg JC Rev Rhum Mal Osteoartic; 1985 Nov; 52(11):650-1. PubMed ID: 4081589 [No Abstract] [Full Text] [Related]
18. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190 [TBL] [Abstract][Full Text] [Related]
19. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus. Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442 [TBL] [Abstract][Full Text] [Related]
20. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]